AQR Arbitrage’s ZyVersa Therapeutics ZVSA Stock Holding History

AQR Arbitrage’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-523	Closed	-$1.83M	–	1255
2022 Q3	$1.83M	Hold	523	–	–	0.04%	505
2022 Q2	$1.82M	Sell	523 -6	-1%	-$20.9K	0.04%	474
2022 Q1	$1.83M	Buy	+529	New	+$1.83M	0.05%	391

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

AQR Arbitrage's ZVSA Position: Q4 2022 in Review

AQR Arbitrage sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 523 shares — an estimated $1.83M sold.

AQR Arbitrage first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $1.83M in Q1 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

AQR Arbitrage reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 523 ZyVersa Therapeutics shares in Q4 2022, an estimated $1.83M.
AQR Arbitrage first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
AQR Arbitrage's ZyVersa Therapeutics position peaked at $1.83M in Q1 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.